argenx SE
Change company Symbol lookup
Select an option...
ARGX argenx SE
ENZC Enzolytics Inc
GREE Greenidge Generation Holdings Inc
MLM Martin Marietta Materials Inc
ERESW East Resources Acquisition Equity Warrant Exp 1st July 2027 *W EXP 07/01/2027
NRAC Noble Rock Acquisition Corp
DCGO DocGo Inc
VELOW Velocity Acquisition Equity Warrant Exp 24 Feb 2028 *W EXP 02/24/2028
MRC MRC Global Inc
BAC Bank of America Corp
Go

Health Care : Biotechnology | Mid Cap Growth
Based in Netherlands
Company profile

argenx SE, formerly arGEN X BV, is the Netherlands-based biopharmaceutical company. It creates and develops a pipeline of differentiated antibody therapeutics using its discovery platform, Simple Antibody, which exploits characteristics of the llama immune system. The Company develops a pipeline of antibody therapeutics focused on cancer and autoimmune indications. It includes: ARGX-110, an antibody for heme malignancies and solid tumors, which modulates functions of tumor such as cell proliferation and survival; ARGX-111, an antagonist of c-Met, a receptor tyrosine kinase involved in cell proliferation, angiogenesis and metastasis in multiple solid tumors; ARGX-112, an antigen which targets atopic dermatitis by neutralization of IL-20 and IL-22 (interleukin) mediated signaling through blockade of their common receptor, among others.

This security is an American depositary receipt
ADR Fees
American Depositary Receipt (ADR) Fee

ADR fees charged by custodial banks normally average from 1 to 3 cents per share. Other country fees might apply. To read more, see the Exception Fees tab at Brokerage Fees

Closing Price
$311.64
Day's Change
21.35 (7.35%)
Bid
--
Ask
--
B/A Size
--
Day's High
314.50
Day's Low
302.69
Volume
(Average)
Volume:
487,639

10-day average volume:
512,527
487,639

Dow's 263-point Drop Led By Losses In Shares Of IBM, Merck

9:46 am ET January 11, 2022 (MarketWatch)
Print

This article was automatically generated by MarketWatch using technology from Automated Insights.

Shares of IBM and Merck are retreating Tuesday morning, dragging the Dow Jones Industrial Average into negative territory. The Dow DJIA was most recently trading 263 points lower (-0.7%), as shares of IBM IBM and Merck MRK are contributing to the index's intraday decline. IBM's shares have fallen $6.04, or 4.5%, while those of Merck are off $1.17 (1.4%), combining for a roughly 47-point drag on the Dow. Also contributing significantly to the decline are Caterpillar CAT, Johnson & Johnson JNJ, and Procter & Gamble PG. A $1 move in any of the benchmark's 30 components results in a 6.59-point swing.

Data source: Dow Jones Market Data, FactSet. Data compiled Janurary 11, 2022.

-MarketWatch Automation

	

(END) Dow Jones Newswires

January 11, 2022 09:46 ET (14:46 GMT)

Copyright (c) 2022 Dow Jones & Company, Inc.

Earnings Calendar and Events Data provided by |Terms of Use| © 2022 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

Information and news provided by ,, , Computrade Systems, Inc., ,, and

Copyright © 2022. All rights reserved.